Social network to promote Italy-USA business and scientific collaborations in Biotech, Nanotech, Cleantech and High-tech.

Loading feed
Alessandra Luchini, from George Mason University, already winner of the 2009 "The Premio Award" created by Bridges to Italy in collaboration with ITWIIN, was invited to Helsinki at the beginning of...
Tagged: euwiin, Itwiin, award, premio, George
Started by bianca dellepiane in Bridges to Italy News Oct 23.
Product Manager and Sales Engineers- Industrial Machinery and Wind Towers. The companies are European leaders in industrial machinery and they are currently expanding their operations in the U.S. ...
Tagged: renewable, energy, Alternative, OPENINGS, JOB
Started by bianca dellepiane in Quick Notes Sep 22.
In the Sept 18, 2009, issue of Cell, a team of Italian and Swiss researchers described part of how cancer stem cells keep on going. Loss of the tumor suppressor p53 shifts the way in which they div...
Tagged: cells, stem, cancer, Biotechnology
Started by bianca dellepiane in Quick Notes Sep 21.
17 members
4 members
13 members
8 members
13 members
Posted by Sharon Weshler on November 5, 2009 at 2:59am
Posted by bianca dellepiane on November 2, 2009 at 6:16pm
PRA International has opened a new office in Milan, Italy, boosting visibility in the country’s competitive contract trials sector.Posted by bianca dellepiane on October 27, 2009 at 5:59am
Elderly people exhibiting memory disturbances that do not affect their normal, daily life suffer from a condition called "mild cognitive impairment" (MCI). Some MCI patients go on to develop Alzheimer's disease within a few years, whereas other cases remain stable, exhibiting onl… Continue Posted by bianca dellepiane on October 24, 2009 at 10:40am

Posted by bianca dellepiane on October 23, 2009 at 4:00pm
An Italian-French "quantum optics" team, has just published an article on the superfluidity of polaritons in semiconductor microcavities in Nature PhysicsPosted by bianca dellepiane on October 23, 2009 at 1:52pm
MolMed S.p.A. (Milan:MLM) recently announced that the U.S. Food and Drug Administration has granted Orphan Drug designation of MolMed’s investigational new antitumour drug NGR-hTNF for treatment of liver cancer (reference code #05-20044). Orphan Drug designation of NGR-hTNF for liver can… Continue Posted by bianca dellepiane on October 23, 2009 at 12:50pm
Posted by bianca dellepiane on September 21, 2009 at 7:51pm
Posted by bianca dellepiane on September 21, 2009 at 7:23pm

Posted by bianca dellepiane on August 31, 2009 at 11:53am
Posted by bianca dellepiane on August 18, 2009 at 2:00pm
Posted by bianca dellepiane on August 17, 2009 at 12:00pm — 2 Comments
Axxam SpA and Xenome Limited have entered a research collaboration agreement to combine Xenome’s expertise in peptide chemistry and peptide drug development with Ax… Continue Posted by bianca dellepiane on August 10, 2009 at 5:34pm
Posted by Sharon Weshler on August 6, 2009 at 11:42am

Posted by bianca dellepiane on July 29, 2009 at 12:30pm

Posted by bianca dellepiane on July 29, 2009 at 9:30am
New analysis of the incidence of breast cancer in Italy per 100,000 women between the ages of 0 to 84 from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick of +28.6 percent found in the youngest group studied (ages 25 to 4… Continue Posted by bianca dellepiane on July 23, 2009 at 6:00pm
They envisioned it at the NEST laboratory in Pisa (a joint INFM-CNR and Scuola Normale Superiore di Pisa la… Continue Posted by bianca dellepiane on July 18, 2009 at 8:00am
Italian scientists say that new research offers hope for sufferers of neurodegenerative diseases such as Parkinson`s, Alzheimer`s and Huntington`s that currently have no cure.Posted by bianca dellepiane on July 14, 2009 at 10:00am
The following article appeared on the Italian magazine OGGI - Sunday Edition:Posted by bianca dellepiane on July 13, 2009 at 9:00am
Loading feed
© 2009 Created by bianca dellepiane on Ning. Create Your Own Social Network